187 related articles for article (PubMed ID: 21965776)
21. Treatment options in patients with metastatic gastric cancer: current status and future perspectives.
Bilici A
World J Gastroenterol; 2014 Apr; 20(14):3905-15. PubMed ID: 24744580
[TBL] [Abstract][Full Text] [Related]
22. Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.
Garrido M; Fonseca PJ; Vieitez JM; Frunza M; Lacave AJ
Expert Rev Anticancer Ther; 2014 Aug; 14(8):887-900. PubMed ID: 24953238
[TBL] [Abstract][Full Text] [Related]
23. Current status and future prospects of chemotherapy for metastatic gastric cancer: a review.
Ohtsu A
Gastric Cancer; 2005; 8(2):95-102. PubMed ID: 15864716
[TBL] [Abstract][Full Text] [Related]
24. Current status of therapy for advanced gastric carcinoma.
Ajani JA
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):99-102. PubMed ID: 9726100
[TBL] [Abstract][Full Text] [Related]
25. Targeted therapy for gastric adenocarcinoma.
Almhanna K
Adv Pharmacol; 2012; 65():437-70. PubMed ID: 22959034
[TBL] [Abstract][Full Text] [Related]
26. Future perspectives for the development of chemotherapy for advanced gastric cancer: Japanese and global status.
Higuchi K; Tanabe S; Azuma M; Sasaki T; Ishido K; Koizumi W
Pathobiology; 2011; 78(6):334-42. PubMed ID: 22104205
[TBL] [Abstract][Full Text] [Related]
27. Geographic differences in approach to advanced gastric cancer: Is there a standard approach?
Kim R; Tan A; Choi M; El-Rayes BF
Crit Rev Oncol Hematol; 2013 Nov; 88(2):416-26. PubMed ID: 23764501
[TBL] [Abstract][Full Text] [Related]
28. Evolving standards of care in advanced gastric cancer.
Kurtz JE; Dufour P
Future Oncol; 2011 Dec; 7(12):1441-50. PubMed ID: 22112319
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy for metastatic gastric cancer in Japan.
Boku N
Int J Clin Oncol; 2008 Dec; 13(6):483-7. PubMed ID: 19093174
[TBL] [Abstract][Full Text] [Related]
30. Second-line chemotherapy for advanced gastric cancer in Korea.
Baek SK; Kim SY; Jeong JH; Cho KS; Yoon HJ
Gastric Cancer; 2012 Oct; 15(4):345-54. PubMed ID: 22410800
[TBL] [Abstract][Full Text] [Related]
31. Systemic treatment of gastric cancer.
Dickson JL; Cunningham D
Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):255-63. PubMed ID: 15195888
[TBL] [Abstract][Full Text] [Related]
32. [Advances in secondary chemotherapy for gastric cancer].
Minashi K; Hironaka S
Gan To Kagaku Ryoho; 2015 Apr; 42(4):398-402. PubMed ID: 25963686
[TBL] [Abstract][Full Text] [Related]
33. Management of advanced gastric cancer.
Price TJ; Shapiro JD; Segelov E; Karapetis CS; Pavlakis N; Van Cutsem E; Shah MA; Kang YK; Tebbutt NC
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):199-208; quiz 209. PubMed ID: 22375525
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy for advanced gastric cancer: across the years for a standard of care.
Scartozzi M; Galizia E; Verdecchia L; Berardi R; Antognoli S; Chiorrini S; Cascinu S
Expert Opin Pharmacother; 2007 Apr; 8(6):797-808. PubMed ID: 17425475
[TBL] [Abstract][Full Text] [Related]
35. Advanced gastroesophageal carcinoma: an update on the current therapeutic landscape.
Hayashi Y; Blum MA; Ajani JA
Onkologie; 2012; 35(4):204-9. PubMed ID: 22488092
[TBL] [Abstract][Full Text] [Related]
36. [Molecular targeting agents for advanced or recurrent gastric cancer patients].
Fuse N
Nihon Rinsho; 2012 Oct; 70(10):1819-26. PubMed ID: 23198568
[TBL] [Abstract][Full Text] [Related]
37. Advancing pharmacological treatment options for advanced gastric cancer.
Sudo K; Yamada Y
Expert Opin Pharmacother; 2015; 16(15):2293-305. PubMed ID: 26359224
[TBL] [Abstract][Full Text] [Related]
38. Second-line Treatment of Advanced Gastric Cancer: Current Options and Future Perspectives.
Chrom P; Stec R; Szczylik C
Anticancer Res; 2015 Sep; 35(9):4575-83. PubMed ID: 26254345
[TBL] [Abstract][Full Text] [Related]
39. What is the reference cytotoxic regimen for advanced gastric cancer: standard versus optimal therapy?
Sohal DP; Sun W
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1843-50. PubMed ID: 22117152
[TBL] [Abstract][Full Text] [Related]
40. Brief review of advances in the treatment of gastric carcinoma in North America and Europe, 1995-2001.
Hasham-Jiwa N; Kasakura Y; Ajani JA
Int J Clin Oncol; 2002 Aug; 7(4):219-24. PubMed ID: 12202975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
